Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Talazoparib tosylate

Product Specifications

UNSPSC Description

Talazoparib tosylate (BMN 673ts) is a novel, potent and orally available PARP1/2 inhibitor with an IC50 of 0.57 nM for PARP1.

Target Antigen

PARP

Type

Reference compound

Related Pathways

Cell Cycle/DNA Damage;Epigenetics

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/Talazoparib_tosylate.html

Purity

99.95

Solubility

DMSO : ≥ 108 mg/mL|H2O : < 0.1 mg/mL

Smiles

O=C1NN=C2C3=C1C=C(F)C=C3N[C@H](C4=CC=C(F)C=C4)[C@H]2C5=NC=NN5C.O=S(C6=CC=C(C)C=C6)(O)=O

Molecular Weight

552.55

References & Citations

[1]Shen Y, et al. BMN 673, a novel and highly potent PARP1/2 inhibitor for the treatment of human cancers with DNA repair deficiency. Clin Cancer Res. 2013 Sep 15;19(18):5003-15.DNA Repair (Amst). 2019 Jan;73:64-70.|ACS Appl Mater Interfaces. 2019 Apr 3;11(13):12342-12356. |Adv Sci (Weinh). 2024 Jul 8:e2400140.|Adv Sci (Weinh). 2024 Mar 14:e2307940.|Am J Cancer Res. 2020 Aug 1;10(8):2649-2676.|Am J Cancer Res. 2024 Jan 15;14(1):378-389.|Bioeng Transl Med. 2019 Jun 14;4(2):e10131. |Bioinformatics. 2022 Jul 26;btac533.|Biomed Res Int. 2023 Feb 6.|bioRxiv. 2023 Apr 17.|bioRxiv. 2023 Jun 22.|bioRxiv. 2023 Jun 28.|bioRxiv. 2024 Jul 10:2024.07.09.602803.|bioRxiv. 2024 Nov 26:2024.11.21.624591.|bioRxiv. April 22, 2021.|BMC Cancer. 2022 Mar 23;22(1):312.|Br J Cancer. 2024 May 28.|Cancer Cell Int. 2023 Jun 27;23(1):128.|Cancer Cell. 2020 Dec 14;38(6):844-856.e7.|Cancer Discov. 2017 Sep;7(9):984-998.|Cancer Discov. 2022 May 12;candisc.1181.2021.|Cancer Lett. 2021 Jan 22;S0304-3835(21)00024-0.|Cancer Lett. 2021 Mar 1;500:208-219.|Cancer Lett. 2022 Aug 1;215851.|Cancer Res. 2021 Jun 14.|Cancer Res. 2023 Sep 11.|Cell Biosci. 2024 Feb 6;14(1):20.|Cell Rep. 2023 Oct 16;42(10):113256.|Cell Rep. 2024 Jul 18;43(8):114522.|Clin Cancer Res. 2017 Feb 15;23(4):1001-1011. |Data Brief. 22 September 2021, 107394.|Département de Pharmacologie et Physiologie, Faculté de Médecine. 2020 Jun.|Drug Des Devel Ther. 2020 Feb 25;14:783-793.|EBioMedicine. 2018 Dec;38:47-56. |EBioMedicine. 2020 Sep;59:102923.|Front Oncol. 2021 Jul 9;11:681441.|Genes (Basel). 2023 Jun 20, 14(6), 1295.|Int J Cancer. 2024 Apr 15.|Int J Mol Sci. 2022, 23(22), 14338|Int J Mol Sci. 2020 Feb 11;21(4):1185.|Integr Biol (Camb). 2019 Apr 1;11(4):130-141.|Invest New Drugs. 2021 Mar 12.|J Clin Invest. 2021 Jun 1;131(11):146256.|J Med Chem. 2023 Aug 21.|J Pers Med. 2023 Aug 27, 13(9), 1315.|Methods Mol Biol. 2018;1711:351-398.|Mol Cell. 2017 May 18;66(4):503-516.e5. |Nat Cancer. 2022 Oct;3(10):1211-1227.|Nat Commun. 2023 Dec 9;14(1):8161.|Nat Commun. 2019 Jun 11;10(1):2556. |Nat Genet. 2022 Dec;54(12):1983-1993.|Neoplasia. 2019 Jul 27;21(9):863-871.|Oncogene. 2017 Aug 17;36(33):4682-4691.|Oncogene. 2021 Sep 10.|Oncol Rep. 2019 Nov;42(5):2097-2107.|Oxid Med Cell Longev. 14 Jul 2022.|Patent. US20180263995A1.|Patent. US20180362972A1.|Patent. US20200078369A1|Patent. US20200129476A1|Patent. US20210030680A1.|Patent. US20220054606A1.|PLoS One. 2024 Apr 16;19(4):e0302130.|Radiother Oncol. 2021 Jan 29;157:175-181.|Research Square Preprint. 2024 Feb 2.|Research Square Print. January 4th, 2023.|Sci Adv. 2022 Feb 18;8(7):eabl9794.|Sci Rep. 2023 Feb 27;13(1):3334.|Theranostics. 2020 Jul 25;10(21):9477-9494. |University of London. 2021 Sep.|University of Pittsburgh. 2024.

Shipping Conditions

Room Temperature

Storage Conditions

4°C (Powder, sealed storage, away from moisture)

Product Datasheet

http://file.medchemexpress.com/batch_PDF/HY-108413/Talazoparib-tosylate-DataSheet-MedChemExpress.pdf

Product MSDS

http://file.medchemexpress.com/batch_PDF/HY-108413/Talazoparib-tosylate-SDS-MedChemExpress.pdf

Clinical Information

Launched

CAS Number

1373431-65-2

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

Human STRN4 siRNA
abx935547-01 15 nmol

Human STRN4 siRNA

Ask
View Details
Human STRN4 siRNA
abx935547-02 30 nmol

Human STRN4 siRNA

Ask
View Details
HOXB7 (HOX2C, Homeobox Protein Hox-B7, Homeobox Protein HHO.C1, Homeobox Protein Hox-2C) (MaxLight 750)
MBS6233289-01 0.1 mL

HOXB7 (HOX2C, Homeobox Protein Hox-B7, Homeobox Protein HHO.C1, Homeobox Protein Hox-2C) (MaxLight 750)

Ask
View Details
HOXB7 (HOX2C, Homeobox Protein Hox-B7, Homeobox Protein HHO.C1, Homeobox Protein Hox-2C) (MaxLight 750)
MBS6233289-02 5x 0.1 mL

HOXB7 (HOX2C, Homeobox Protein Hox-B7, Homeobox Protein HHO.C1, Homeobox Protein Hox-2C) (MaxLight 750)

Ask
View Details
2,6-dichloro-3-isopropylpyrimidin-4 (3H) -one
RG-E140778-01 10 mg

2,6-dichloro-3-isopropylpyrimidin-4 (3H) -one

Ask
View Details
2,6-dichloro-3-isopropylpyrimidin-4 (3H) -one
RG-E140778-02 25 mg

2,6-dichloro-3-isopropylpyrimidin-4 (3H) -one

Ask
View Details